Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates

American Journal of Human Genetics

Volumn 72, Issue 4, 2003, Pages 869-878

  Jacquemont, Sébastien ^a   Hagerman, Randi J ^a,b   Leehey, Maureen ^d   Grigsby, Jim ^d   Zhang, Lin ^b   Brunberg, James A ^b   Greco, Claudia ^b   Des Portes, Vincent ^a   Jardini, Tristan ^a   Levine, Richard ^h   Berry Kravis, Elizabeth ^e   Brown, W Ted ^f   Schaeffer, Stephane ^a   Kissel, John ^g   Tassone, Flora ^c   Hagerman, Paul J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^g THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^h SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CEREBELLAR ATAXIA; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; FEMALE; FRAGILE X SYNDROME; HUMAN; LEG; MALE; MOLECULAR BIOLOGY; MOTOR DYSFUNCTION; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SHORT TERM MEMORY; TREMOR; WHITE MATTER;

ATAXIA;

EID: 0037384643     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/374321     Document Type: Article

References (36)

1. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, et al. (1999) Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study - preliminary data. Am J Med Genet 83:322-325
2. Bhattacharya K, Saadia D, Eisenkraft B, Yahr M, Olanow W, Drayer B, Kaufmann H (2002) Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol 59:835-842
3. Brown WT, Houck GE Jr, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC (1993) Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270:1569-1575
4. Brunberg J, Jacquemont S, Hagerman RJ, Berry-Kravis EM, Grigsby J, Leehey MA, Tassone F, Brown WT, Greco CM, Hagerman PJ (2002) Fragile X premutation carriers: characteristic MR imaging findings in adult male patients with progressive cerebellar and cognitive dysfunction. Am J Neurol Radiol 23:1757-1766
5. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340
6. Dombrowski C, Levesque S, Morel ML, Rouillard P, Morgan K, Rousseau F (2002) Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 11:371-378
7. Dorn MB, Mazzocco MM, Hagerman RJ (1994) Behavioral and psychiatric disorders in adult male carriers of fragile X. J Am Acad Child Adolesc Psychiatry 33:256-264
8. Fahn S, Elton RL, UPDRS Development Committee (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Godstein M (eds) Recent developments in Parkinson's disease. Macmillan Health Care Information, Florham Park, NJ, pp 153-164
9. Fahn S, Tolosa E, Marin C (1998) Clinical rating scale for tremor. In: Jankovic J, Tolosa E (eds) Parkinson's disease and movement disorders. Urban & Schwarzenberg, Baltimore, pp 225-234
10. Franke P, Leboyer M, Gansicke M, Weiffenbach O, Biancalana V, Cornillet-Lefebre P, Croquette MF, Froster U, Schwab SG, Poustka F, Hautzinger M, Maier W (1998) Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychr Res 80:113-127
11. Franke P, Maier W, Hautzinger M, Weiffenbach O, Gansicke M, Iwers B, Poustka F, Schwab SG, Froster U (1996) Fragile-X carrier females: evidence for a distinct psychopathological phenotype. Am J Med Genet 64:334-339
12. Goodglass H, Kaplan E (1983) The assessment of aphasia and related disorders, 2nd ed. Lea & Febiger, Philadelphia
13. Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont S, Leehey M, Hagerman PJ (2002) Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125:1760-1771
14. Grigsby J, Kaye K, Baxter J, Shetterly SM, Hamman RF (1998) Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study. J Am Geriatr Soc 46:590-596
15. Hagerman PJ, Greco C, Hagerman RJ, Tassone T, Chudley AE, Del Bbigio MR, Jacquemont S, Gane L, Leehey M (2002) Neuronal intranuclear inclusions in a tremor/ataxia syndrome among fragile X premutation carriers. Am J Hum Genet Suppl 71:A508
16. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-130
17. Kenneson A, Zhang F, Hagedorn CH, Warren ST (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10:1449-1454
18. Leehey M, Munhoz RP, Lang AE, Brunberg J, Grigsby J, Greco C, Jacquemont S, Tassone F, Lozano AM, Hagerman PJ, Hagerman R (2003) The fragile X premutation presenting as essential tremor. Arch Neurol 60:117-121
19. Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289:1769-1773
20. Naka H, Ohshita T, Murata Y, Imon Y, Mimori Y, Nakamura S (2002) Characteristic MRI findings in multiple system atrophy: comparison of the three subtypes. Neuroradiology 44:204-209
21. Oberle L, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102
22. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822
23. Riddle JE, Cheema A, Sobesky WE, Gardner SC, Taylor AK, Pennington BF, Hagerman RJ (1998) Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard 102:590-601
24. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K (1995) Prevalence of carriers of premutation-size alleles of the FMRI gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57:1006-1018
25. Schwartz CE, Dean J, Howard Peebles PN, Bugge M, Mikkelsen M, Tommerup N, Hull C, Hagerman R, Holden JJ, Stevenson RE (1994) Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet 51:400-402
26. Sobesky WE (1996) The treatment of emotional and behavioral problems in fragile X syndrome. In: Hagerman RJ, Cronister A (eds) Fragile X syndrome: diagnosis, treatment, and research, 2nd ed. The Johns Hopkins University Press, Baltimore, pp 332-348
27. Spreen O, Benton AL (ed) (1977) Neurosensory Center Comprehensive Examination for Aphasia (NCCEA) - Revised. University of Victoria Neuropsychology Laboratory, Victoria, Canada
28. Tassone F, Hagerman RJ, Chamberlain W, Hagerman P (2000a) Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet 97:195-203
29. Tassone F, Hagerman RJ, Iklé DN, Dyer PN, Lampe M, Willemsen R, Oostra B, Tayor AK (1999) FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 84:250-261
30. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ (2000b) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in fragile X syndrome. Am J Hum Genet 66:6-15
31. Taylor AK, Safanda JF, Fall MZ, Quince C, Lang KA, Hull CE, Carpenter I, Staley LW, Hagerman RJ (1994) Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA 271:507-514
32. Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC, Massaquoi S, Gomez CM, Coutinho P, Ben Hamida M, Campanella G, Filla A, Schut L, Timann D, Honnorat J, Nighoghossian N, Manyam B (1997) International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 145:205-211
33. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, Eussen BE, Van Ommen JB, Blonden LA, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 3165:905-914
34. Wechsler D (1997) WAIS-III: Wechsler Adult Intelligence Scale-Third Edition: administration and scoring manual. The Psychological Corporation, San Antonio, TX
35. Willemsen R, Mohkamsing S, de Vries B, Devys D, van den Ouweland A, Mandel JL, Galjaard H, Oostra B (1995) Rapid antibody test for fragile X syndrome. Lancet 345:1147-1148
36. Willemsen R, Smits A, Mohkamsing S, van Beerendonk H, de Haan A, de Vries B, van den Ouweland A, Sistermans E, Galjaard H, Oostra BA (1997) Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet 99:308-311